This is the second edition of ‘a quiet revolution: Drug Decriminalisation across the Globe’. the rst edition was released in July 2012 and has since been cited by a wide range of organisations and agencies, including: the World Health organisation, the of ce of the united nations High Commissioner for Human rights, and the Global Commission on Drug Policy.

Exploring a key concern about decriminalising or regulating drugs

Prohibition, privilege and the drug apartheid: The failure of drug policy reform to address the underlying fallacies of drug prohibition

A guidance paper on testing in community and harm reduction settings.

The Strategy aims to contribute to a reduction in drug demand and drug supply within the EU. It also aims to reduce the health and social risks and harms caused by drugs through a strategic approach that supports and complements national policies, that provides a framework for coordinated and joint actions and that forms the basis and political framework for EU external cooperation in this field. This will be achieved through an integrated, balanced and evidence-based approach.

United Nations entities recall that a central principle of the 2030 Agenda for Sustainable Development is to “ensure that no one is left behind” and to “reach the furthest behind first”.

The Sustainable Development Goals and criminal justice.

President Trump promised to repeal the Affordable Care Act (ACA), and although it took some negotiating, he got what he wanted from the House of Representatives on May 3. That’s when the House passed the American Health Care Act (AHCA), repealing key provisions of the ACA.

Portugal has reduced DRDs by a whole package of care, including decriminalisation. By internationally accepted measure of drug-related deaths, deaths due to drug use have decreased significantly – from approximately 80 in 2001, to 16 in 2012.

Overdose prevention, naloxone, and human rights in the United States.

Information PDF

What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 European Drug Report, our annual overview of the drug situation in Europe.

Austerity, international donor retreat and poor political support are severely limiting harm reduction responses in several European Union (EU) countries.

Edited by a global team of psychiatrists experienced in the treatment of addiction.

Prioritizing restrictive control is to the detriment of ensuring adequate availability of and access to controlled medicines, violating the rights of people who need them.

The next step in addiction is assisting those who use heroin to inject.

Written by Prof John Dillon, Professor of Hepatology & Gastroenterology School of Medicine, University of Dundee, Ninewells Hospital and Medical school.

The straight answer is that we do not know exactly how many drug-related deaths there are in the UK. This is because it depends on what definition of drug-related deaths is used, which is not a simple question.

The 22nd International AIDS Conference (AIDS2018) that will be held in Amsterdam 23 - 27 July 2018 will have special attention for Eastern Europe and Central Asia.

The purpose of this paper is to explain how international drug policy continues to have a hugely damaging effect on population health, human rights and wellbeing, not only on individuals who consume and/or sell drugs but also on societies as a whole. And to review whether anything has changed after United Nations General Assembly Special Session.

More than 8 000 lives were reported to be lost to drug overdoses in Europe (EU28 plus Turkey and Norway) in the past year and this is an underestimate. Reducing drug-related deaths therefore remains a major challenge for public health policy. This analysis describes some of the factors that increase the risk of fatal and non-fatal overdoses and a number of interventions developed to prevent these events.

Opioid overdose is treatable with naloxone, an opioid antagonist which rapidly reverses the effects of opioids. Death does not usually occur immediately, and in the majority of cases, overdoses are witnessed by a family member, peer or someone whose work brings them into contact with people who use opioids. Increased access to naloxone for people likely to witness an overdose could significantly reduce the high numbers of opioid overdose deaths.

The objective was to compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and to characterise trends in risk of mortality after initiation and cessation of treatment.

Global drug control is based on three international conventions from 1961, 1971 and 1988, which all open with a commitment to promote the ‘health and welfare of mankind’.Yet the 1961 and 1971 Conventions make no reference to human rights, and the term only appears once in the 1988 Convention in the context of crop eradication.

Humankind has the capacity and knowledge to eliminate the Hepatitis C virus from Earth - but stigma, prejudice and greed stand in the way. Watch the Drugreporter movie produced in cooperation with the Correlation Network and learn more.

The latest figures from the National Drug-Related Deaths Index (NDRDI) show that a total of 697 deaths in Ireland during 2014 were linked to drug use.

Practical guidance for collaborative interventions.

A multi-disciplinary study has shown that the recent substantial increase in prescriptions for two drugs, pregabalin and gabapentin is closely correlated with a rise in the number of overdose deaths in England and Wales.

In January 2015 this hot topic tentatively relayed some good and not so good news: “The year 2013 may prove to have been a turning point in drug-related deaths in the UK.."

Non-medical use of prescription opioids is now the fourth most-prevalent form of substance use in Canada; it trails only alcohol, tobacco, and cannabis.